SINGLETON J MATTHEW 4
4 · Viking Therapeutics, Inc. · Filed Aug 22, 2024
Insider Transaction Report
Form 4
SINGLETON J MATTHEW
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-08-21−5,700→ 10,300 totalExercise: $1.19From: 2018-01-03Exp: 2027-01-03→ Common Stock (5,700 underlying) - Exercise/Conversion
Common Stock, par value $0.00001 per share
2024-08-21$1.19/sh+5,700$6,783→ 15,200 total - Sale
Common Stock, par value $0.00001 per share
2024-08-21$69.72/sh−5,700$397,430→ 9,500 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 16, 2024 by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.50 to $69.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.